Monocular Glaucoma Drop Trial A Failure
July 18, 2009
Submit Comments
In the past few years, one or two articles came out that suggested that that the time-honored practice of doing a monocular trial to check the IOP lowering effect just doesn’t work. It seems that there is just too much variability in IOP between the eyes and on a day-to-day/diurnal basis. An article in this month’s Ophthalmology seems to be the final nail in that coffin. I abandoned the trial a couple of years ago and am relieved that I did the right thing.
You might also enjoy...
- Is Frequency Doubling Technology Perimetry Superior to Standard Automated Perimetry in Detecting Glaucoma?
- Yeesh! Monocular Trial For Glaucoma Drops Useful After All?
- Vascular Abnormalities in Nail Bed Suggestive of Glaucoma
- Is it Okay to Observe Patients at Low Risk For Ocular Hypertension?
- Do Travoprost Eye Drops Produce Lower Diurnal IOP Than Tafluprost Eye Drops?
Comments
Jump down to form below to submit your own comments
